The largest database of trusted experimental protocols

3 protocols using percp cyanine5.5 anti human cd8

1

Multiparametric Phenotyping of Stimulated PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stimulated PBMCs were recovered from the culture plates and resuspended in 100 μL PBS. Cell viability was assessed by staining with Viobility™ Fixable Dyes (Miltenyi Biotec, Germany). Cells were washed, fixed, permeabilized, and then stained with an antibody cocktail containing Pacific Blue™ anti-human CD3 (Biolegend, clone: HIT3a), PE/Cyanine7 anti-human CD4 (Biolegend, clone:A161A1) and PerCP/Cyanine5.5 anti-human CD8 (Biolegend, clone: SK1) for T cell identification; APC anti-human CD69 (Biolegend, clone: FN50) and PE anti-human IFN-γ (Biolegend, clone:4S.B3) for the activation analysis; and FITC anti-human CD14 (Biolegend, clone:HCD14) and FITC anti-human CD20 (Biolegend, clone:2H7) for the exclusion of non-specific signals and B cells. Fifty thousand events were analyzed by a BD LSR-II flow cytometer. (BD Biosciences, San Jose, CA) The gates applied for the quantification of the stimulated T cells are illustrated in Figure S1.
+ Open protocol
+ Expand
2

Single-Cell ATAC-Seq of Human PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human PBMCs were thawed after storage in liquid nitrogen and allowed to recover overnight in R10 culture medium (RPMI1640 medium supplemented with 10% fetal calf serum (FCS), 25 mM HEPES, 1* nonessential amino acids, 50 μM β-mercaptoethanol, and 1 × penicillin and streptomycin). Cell surface staining was performed with the following antibodies: DAPI, Alexa Fluor® 700 anti-human CD3 (Clone SK7, 1:100, BioLegend, Cat #344822), FITC anti-human TCR α/β (Clone IP26, 1:50, BioLegend, Cat #306706), PerCP/Cyanine5.5 anti-human CD8 (Clone SK1, 1:200, BioLegend, Cat #344710), PE/Dazzle™ 594 anti-human CD4 (Clone A161A1, 1:200, BioLegend, Cat #357411), PE anti-human CD25 (Clone BC96, 1:200, BioLegend, Cat #302606), Brilliant Violet 650™ anti-human CD127 (Clone A019D5, 1:200, BioLegend, Cat #351326), APC anti-human CD137 (4– 1BB) (Clone 4B4–1, 1:100, BioLegend, Cat #309810), Brilliant Violet 605 anti-human CD279 (PD-1) (Clone EH12.2H7, 1:100, BioLegend, Cat #329923). Single viable DAPI-CD3+TCRaß+ T cells were immediately indexed sorted into 96-well plates for Ti-ATAC-seq analysis using BD FACS Aria III.
+ Open protocol
+ Expand
3

Multiparametric Flow Cytometry for Immune Cell Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
All antibodies used were commercially available and validated for specificity by the manufacturer. Allophycocyanin (APC) anti-human IL-2 (MQ1-17H12, 1:20) and BD Horizon™ BV786 anti-human IFN-γ (4S.B3, 1:20) were purchased from BD Biosciences. Alexa Fluor 700 anti-human CD28 (CD28.2, 1:20), APC anti-human CD161 (HP-3G10, 1:10), Brilliant Ultraviolet (BUV) 395 anti-human CD3 (SK7, 1:20), Brilliant Violet 605 anti-human TCR Vα7.2 (3C10, 1:10), Brilliant Violet 650 anti-human CX3CR1 (2A9-1, 1:20), Brilliant Violet 711 anti-human IL-17A (BL168 1:20), Brilliant Violet 711 anti-human perforin (dG9, 1:20), PE/Dazzle 594 anti-human/mouse granzyme B (QA16A02, 1:100), PE/Dazzle 594 anti-human TNF-α (MAb11, 1:100), PE/Cyanine7 anti-human CD4 (SK3, 1:20), and PerCP/Cyanine5.5 anti-human CD8 (SK1, 1:20) were purchased from BioLegend. APC-eFluor™ 780 anti-human CD27 (O323, 1:20) was purchased from eBioscience. Phycoerythrin (PE) anti-human TCR Vδ2 (123R3, 1:100), fluorescein isothiocyanate (FITC) anti-human TCRγ/δ (REA591, 1:10), and VioBlue anti-human TCR Vδ1 (REA173, 1:10) were purchased from Miltenyi Biotec. Dead cells were excluded using the viability dye Zombie Aqua™ Fixable Viability Kit (BioLegend) according to the manufacturer’s instructions.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!